Specificity for the detection of recurrence: related to the cut-point used CEA > 5 ng/ml : 5% of false positive results CA 15.3 > 35 U/ml: 6,5% of false positive results U i hi h ff l (CA 1 3 60 U/ l CEA 10 / l) d Using higher cut-off values (CA 15.3 60 U/ml, CEA 10 ng/ml) and at least two serial increases (>15%), specificity increased to almost 100%.
ADVANCED DISEASE
Tumor marker sensitivity is significantly higher than in loco-regional disease.
-Combination of several markers (CA15.3, CEA, t k ti ) i th iti it t 90% i ti t cytokeratins) increase the sensitivity to 90% in patients with distant metastases. Tumor marker sensitivity is related to the site of -Tumor marker sensitivity is related to the site of metastases
